[LXRX] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
04-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -0.63%
YoY- -31.11%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 702 162 317 24 28 39 35 634.18%
PBT -48,244 -50,525 -44,904 -31,934 -30,494 -23,387 -24,587 56.53%
Tax -2,977 2,854 1,152 -1,029 216 292 580 -
NP -48,244 -50,525 -44,904 -30,905 -30,710 -23,679 -25,167 54.13%
Tax Rate - - - - - - - -
Total Cost 48,946 50,687 45,221 30,929 30,738 23,718 25,202 55.47%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -6,872.36 -31,188.27 -14,165.30 -128,770.83 -109,678.57 -60,715.38 -71,905.71 -79.00%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.20 -0.21 -0.22 -0.16 -0.16 -0.14 -0.17 11.41%
EPS Diluted -0.20 -0.21 -0.22 -0.16 -0.16 -0.14 -0.17 11.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.